AlphaCentric Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $503K | Sell |
|
|||||
|
2024
Q3 | $2.59M | Buy |
|
|||||
|
2024
Q2 | $964K | Hold |
|
|||||
|
2024
Q1 | $965K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $3.38M | Sell |
|
|||||
|
2023
Q2 | $3.44M | Buy |
|
|||||
|
2023
Q1 | $1.57M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $195K | Sell |
|
|||||
|
2020
Q4 | $268K | Buy |
|
|||||
|
2020
Q3 | $29K | Buy |
|
|||||
|
2020
Q2 | $27K | Buy |
|